These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6236244)

  • 21. Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment.
    Hrdina PD; Bakish D; Ravindran A; Chudzik J; Cavazzoni P; Lapierre YD
    Psychiatry Res; 1997 Feb; 66(2-3):73-85. PubMed ID: 9075272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5HT2-receptors and serotonin release: their role in human platelet aggregation.
    Cerrito F; Lazzaro MP; Gaudio E; Arminio P; Aloisi G
    Life Sci; 1993; 53(3):209-15. PubMed ID: 8321084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral adrenoceptors and serotonin receptors in depression. Changes associated with response to treatment with trazodone or amitriptyline.
    Healy D; Carney PA; O'Halloran A; Leonard BE
    J Affect Disord; 1985 Nov; 9(3):285-96. PubMed ID: 2934461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of ketanserin, a selective 5-HT2 serotonergic antagonist, on the secondary recruitment of human platelets in vitro.
    De Clerck F; Xhonneux B
    Agents Actions; 1986 Mar; 17(5-6):515-26. PubMed ID: 2939698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
    Michal F; Motamed M
    Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study.
    McBride PA; Anderson GM; Hertzig ME; Sweeney JA; Kream J; Cohen DJ; Mann JJ
    Arch Gen Psychiatry; 1989 Mar; 46(3):213-21. PubMed ID: 2919950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors.
    Hrdina PD; Bakish D; Chudzik J; Ravindran A; Lapierre YD
    J Psychiatry Neurosci; 1995 Jan; 20(1):11-9. PubMed ID: 7865496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin-stimulated Ca2+ response is increased in the blood platelets of depressed patients.
    Kusumi I; Koyama T; Yamashita I
    Biol Psychiatry; 1991 Aug; 30(3):310-2. PubMed ID: 1912120
    [No Abstract]   [Full Text] [Related]  

  • 29. Elevated intracellular calcium levels after 5-HT2 receptor stimulation in platelets of depressed patients.
    Eckert A; Gann H; Riemann D; Aldenhoff J; Müller WE
    Biol Psychiatry; 1993 Oct; 34(8):565-8. PubMed ID: 8274585
    [No Abstract]   [Full Text] [Related]  

  • 30. [Inhibition of serotonin-induced platelet aggregation by endothelins].
    Takada A; Takada Y
    Nihon Rinsho; 1992 Feb; 50(2):315-8. PubMed ID: 1613985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blunted serotonergic responsivity in neuroleptic-naïve patients at first-episode of schizophrenia.
    Reddy R; Keshavan M; Yao JK
    Schizophr Res; 2007 Feb; 90(1-3):81-5. PubMed ID: 17204398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin function in affective disorders.
    Grahame-Smith DG
    Acta Psychiatr Scand Suppl; 1989; 350():7-12. PubMed ID: 2683591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serotonin-2 receptor-mediated intraplatelet calcium mobilization in affective disorders: relevance to the pathophysiology of depression].
    Kusumi I
    Hokkaido Igaku Zasshi; 1993 May; 68(3):325-36. PubMed ID: 8319932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical utility of pharmacological agents that act at serotonin receptors.
    Peroutka SJ; Sleight AJ; McCarthy BG; Pierce PA; Schmidt AW; Hekmatpanah CR
    J Neuropsychiatry Clin Neurosci; 1989; 1(3):253-62. PubMed ID: 2562495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonergic receptor subtypes and vascular reactivity.
    Van Nueten JM; Leysen JE; de Clerck F; Vanhoutte PM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 4():S564-74. PubMed ID: 6210424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hallucinogenic drugs are partial agonists of the human platelet shape change response: a physiological model of the 5-HT2 receptor.
    McClue SJ; Brazell C; Stahl SM
    Biol Psychiatry; 1989 Jul; 26(3):297-302. PubMed ID: 2742945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs?
    Stahl S
    Psychopharmacol Bull; 1994; 30(1):39-43. PubMed ID: 7972628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic responses and receptor occupancy in rabbit blood platelets.
    Hallam TJ; Scrutton MC; Wallis RB
    Thromb Res; 1982 Aug; 27(4):435-45. PubMed ID: 7147214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonin and bipolar disorder.
    Mahmood T; Silverstone T
    J Affect Disord; 2001 Sep; 66(1):1-11. PubMed ID: 11532527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noradrenergic and serotonergic abnormalities in depression: stress-induced dysfunction?
    Dinan TG
    J Clin Psychiatry; 1996; 57 Suppl 4():14-8. PubMed ID: 8636061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.